SCHEMBL8950311

SCHEMBL8950311

CCOC(=O)CN(C(C)C)S(=O)(=O)c1sccc1C1OCCO1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
POLB P06746 2/20 0.34
TSHR P16473 2/20 0.33
HSD17B10 Q99714 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
PKM P14618 1/20 0.32
LMNA P02545 1/20 0.30
KDM4E B2RXH2 2/20 0.30
GAA P10253 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950198 0.87 GAA (0.36) ALDH1A1POLBTSHRHSD17B10SMN1; SMN2
SCHEMBL8950221 0.77 HTT (0.45) ALDH1A1TSHRSMN1; SMN2LMNAGAA
SCHEMBL8862623 0.77 ALDH1A1 (0.43) ALDH1A1POLBTSHRSMN1; SMN2PKM
SCHEMBL8950386 0.72 GAA (0.38) ALDH1A1POLBTSHRSMN1; SMN2PKM
SCHEMBL2277778 0.69 ALDH1A1 (0.41) ALDH1A1POLBTSHRHSD17B10SMN1; SMN2
SCHEMBL8950105 0.67 ALDH1A1 (0.39) ALDH1A1POLBSMN1; SMN2LMNAKDM4E
SCHEMBL10373935 0.66 ALDH1A1 (0.45) ALDH1A1POLB
SCHEMBL3017019 0.65 ALDH1A1 (0.41) ALDH1A1POLB
SCHEMBL7117736 0.62 GAA (0.49) ALDH1A1POLBTSHRHSD17B10SMN1; SMN2
SCHEMBL18223814 0.60 PTAFR (0.35) GAACYP1A2CYP3A4MAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022099-A1 OPHTHALMIC COMPOSITIONS FOR TREATING GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-25 WO disclosed
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US disclosed
WO-1995019981-A1 THIENOTHIAZINE SULFONAMIDE DERIVATIVES PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS CARBONIC ANHYDRASE INHIBITORS ALCON LABORATORIES, INC. (US) 1995-07-27 WO disclosed